Filing Details
- Accession Number:
- 0001179110-11-010869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-11 20:22:16
- Reporting Period:
- 2011-07-07
- Filing Date:
- 2011-07-11
- Accepted Time:
- 2011-07-11 20:22:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314870 | Kristen Metza | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-07 | 5,000 | $28.26 | 21,534 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-07 | 5,000 | $42.47 | 16,534 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2011-07-07 | 5,000 | $0.00 | 5,000 | $28.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,500 | 2016-05-09 | No | 4 | M | Direct |
Footnotes
- The stock options have a five year vesting schedule. 20% of the options vested on May 9, 2007, the first anniversary of the grant. The balance vested 5% quarterly thereafter until fully vested on May 9, 2011. The options expire on May 9, 2016.
- Amount of securities beneficially owned following the reported transaction includes 732 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2011.
Billionaire Hedge Funds
